or Try an Advanced Search...

    Cyclacel Stocks List

    Symbol Grade Name % Change
    CYCC D Cyclacel Pharmaceuticals, Inc. -0.43
    CASI F CASI Pharmaceuticals, Inc. -0.64
    CYCCP F Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock 0.00
    ASLN F ASLAN Pharmaceuticals Limited 4.30
    GMDA F Gamida Cell Ltd. 0.00
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Cell Cycle Life Sciences Treatment Of Cancer Autoimmune And Inflammatory Disease Biology Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Checkpoint Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib

    Cyclacel Stocks Recent News

    Date Stock Title
    May 7 ASLN ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Cell Cycle Life Sciences Treatment Of Cancer Autoimmune And Inflammatory Disease Biology Cancer Cell Cdk Inhibitor Cell Biology Cell Cycle Checkpoint Cyclin Dependent Kinase Cyclin Dependent Kinase 2 Dna Synthesis Human Cancers Inflammatory Diseases PLK1 Sapacitabine Seliciclib
    Cyclacel

    Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.
    Major shareholders include Goldman Sachs Group, Tang Capital Management, Redmile Group and Ayer Capital Management.
    The firm is developing "mechanism-targeted drugs" to help in the fight of cancer, and other serious illness, such as diabetes and HIV.

    More about Cyclacel
    Browse All Tags